IXICO PLC (IXI)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

8.50p

Buy

9.50p

arrow-down-0.70p (-7.22%)

IXICO PLC is engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies.
Prices updated at 09 May 2025, 14:02 BST
| Prices minimum 15 mins delay
|
Prices in GBX
FTSE All-Share
arrow-up0.27%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Mark Robert Warne
CEO
Mr. Bram Goorden
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
74
Head office
15 Long Lane
London
United Kingdom
EC1A 9PN
mobile
+44 2037637499
letter
companysecretary@ixico.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Mark Robert Warne
Non-Executive Director, Chairman
-----
Dr. Dipti Mahendra Amin
Non-Executive Director
-----
Ms. Katherine Jane Rogers
Non-Executive Director
-----
Mr. Grant Robert Nash
Executive Director, Chief Financial Officer and Company Secretary
-----
Mr. Bram Goorden
Executive Director, Chief Executive Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Octopus Investments Limited5,827,0270.470633459814-30 Apr 20256.29
Maven Renovar VCT PLC4,442,8570.23844442857-30 Apr 20254.79
Unicorn Asset Management Ltd3,586,0000.15989--30 Apr 20253.87
Unicorn AIM VCT Series 3 ORD3,586,0000.15989--30 Apr 20253.87
Octopus AIM VCT ORD3,427,0270.269213427027-30 Apr 20253.70

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
04 Dec 2024PurchaseMr. Grant Robert Nash12.0231,239505,2631.04-
04 Dec 2024SaleMr. Grant Robert Nash12.0031,200245,2630.26-
28 Oct 2024PurchaseMr. Grant Robert Nash9.5010,000505,2630.55Placing
28 Oct 2024PurchaseDr. Dipti Mahendra Amin9.5010,000105,2630.12Placing
28 Oct 2024PurchaseDr. Dipti Mahendra Amin9.5010,000105,2630.22Placing
28 Oct 2024PurchaseMr. Bram Goorden9.5050,000526,3151.09Placing
28 Oct 2024PurchaseMr. Bram Goorden9.5050,000526,3150.59Placing
28 Oct 2024PurchaseMs. Katherine Jane Rogers9.505,00052,6310.11Placing
28 Oct 2024PurchaseMs. Katherine Jane Rogers9.505,00052,6310.06Placing
10 Oct 2024PurchaseMr. Mark Robert Warne9.482,50072,3350.15-
09 Oct 2024PurchaseMr. Mark Robert Warne9.502,50045,9650.10-
09 Oct 2024Exercise of OptionMr. Grant Robert Nash--400,0000.45-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.